TABLE 5.
Study patients | Control Group: treated with RT and non-TMZ chemo |
Control Group: treated with RT alone |
|
---|---|---|---|
Estimated 1-year survival | 69.4% | 57% | 35% |
Median survival | 65 wks (95% c.i. 54.8–74.2 wks) |
57 wks (95% c.i. 54–62 wks) |
40 wks (95% c.i. 36–44 wks) |